Odysseas Manesiotis
Stock Analyst at Exane BNP Paribas
(0.08)
# 4,609
Out of 4,651 analysts
178
Total ratings
29.4%
Success rate
-14.7%
Average return
Main Sectors:
Stocks Rated by Odysseas Manesiotis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIT: DIA DiaSorin S.p.A. | Downgraded: Sell | €107.00 → €60.00 | €74.42 | -19.38% | 7 | Jul 7, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Initiated Coverage: Hold | €250.00 → €235.00 | €237.50 | n/a | 33 | May 29, 2025 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Initiated Coverage: Buy | €182.00 → €233.00 | €185.50 | n/a | 12 | May 29, 2025 | |
| SWX: LONN Lonza Group AG | Initiated Coverage: Buy | CHF 705.00 | CHF 562.60 | n/a | 1 | May 29, 2025 | |
| AIM: CLBX CelLBxHealth plc | Maintained: Buy | 70p → 30p | 1p | n/a | 17 | May 28, 2025 | |
| QGEN Qiagen | Maintained: Buy | $64 → $58 | $42.95 | n/a | 24 | Feb 24, 2025 | |
| LON: ONT Oxford Nanopore Technologies plc | Maintained: Buy | 282p | 122p | n/a | 20 | Jan 13, 2025 | |
| SWX: TECN Tecan Group AG | Maintained: Buy | CHF 328.00 → CHF 264.00 | CHF 195.80 | n/a | 9 | Nov 15, 2024 | |
| ETR: SBS Stratec SE | Maintained: Buy | €50.00 | €22.00 | n/a | 15 | Oct 18, 2024 | |
| ETR: SHL Siemens Healthineers AG | Maintained: Buy | €58.20 → €57.80 | €39.31 | n/a | 19 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €122.20 | €73.10 | n/a | 9 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 133p → 126p | 69p | n/a | 12 | Mar 13, 2024 |
DiaSorin S.p.A.
Jul 7, 2026
Downgraded: Sell
Price Target: €107.00 → €60.00
Current: €74.42
Upside: -19.38%
Sartorius Aktiengesellschaft
May 29, 2025
Initiated Coverage: Hold
Price Target: €250.00 → €235.00
Current: €237.50
Upside: n/a
Sartorius Stedim Biotech S.A.
May 29, 2025
Initiated Coverage: Buy
Price Target: €182.00 → €233.00
Current: €185.50
Upside: n/a
Lonza Group AG
May 29, 2025
Initiated Coverage: Buy
Price Target: CHF 705.00
Current: CHF 562.60
Upside: n/a
CelLBxHealth plc
May 28, 2025
Maintained: Buy
Price Target: 70p → 30p
Current: 1p
Upside: n/a
Qiagen
Feb 24, 2025
Maintained: Buy
Price Target: $64 → $58
Current: $42.95
Upside: n/a
Oxford Nanopore Technologies plc
Jan 13, 2025
Maintained: Buy
Price Target: 282p
Current: 122p
Upside: n/a
Tecan Group AG
Nov 15, 2024
Maintained: Buy
Price Target: CHF 328.00 → CHF 264.00
Current: CHF 195.80
Upside: n/a
Stratec SE
Oct 18, 2024
Maintained: Buy
Price Target: €50.00
Current: €22.00
Upside: n/a
Siemens Healthineers AG
Sep 25, 2024
Maintained: Buy
Price Target: €58.20 → €57.80
Current: €39.31
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: €122.20
Current: €73.10
Upside: n/a
Mar 13, 2024
Maintained: Buy
Price Target: 133p → 126p
Current: 69p
Upside: n/a